NEW YORK (GenomeWeb News) – ADA Technologies has landed a $1.15 million grant from the National Institutes of Health to develop an analytical tool for analyzing carbohydrate-protein interactions in drug discovery and diagnostics research.

The company will use the three-year Phase 2 funding to develop a microarray platform for rapidly analyzing carbohydrate and protein interactions that serve as cancer biomarkers.

ADA said that there currently is no cost-effective tool for quickly screening for such interactions.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.